Skip to content

Changes to the Supervisory Board

With the registration of the legal form change of Fresenius Medical Care AG, Stefanie Balling left the Supervisory Board of Fresenius SE & Co. KGaA as of November 30, 2023. She was succeeded by Holger Michel, who had already been appointed at the constituent meeting of the European Works Council of Fresenius SE & Co. KGaA on April 29, 2021, as a personal substitute member for Ms. Balling, and thus succeeded her without election.

Changes to the Management Board

Dr. Michael Moser has been a member of the Fresenius Management Board since July 1, 2023, responsible for Legal, Compliance, Risk Management, ESG, and for the Fresenius Vamed business segment. Since December 1, 2023, he has also been responsible for Human Resources, which he took over from Dr. Sebastian Biedenkopf.

Dr. Sebastian Biedenkopf stepped down from the Fresenius Management Board upon expiry of his Management Board appointment on November 30, 2023.

Dr. Ernst Wastler, previously responsible for Fresenius Vamed, stepped down as Chairman of the VAMED Management Board and thus also from the Fresenius Management Board upon reaching retirement age on July 18, 2023.

On September 8, 2023, Fresenius announced that the Supervisory Board of Fresenius Management SE had appointed Robert Möller as a member of the Management Board with immediate effect. At the same time, Robert Möller took over as Chairman of the Management Board of Helios Health GmbH. He succeeded Dr. Francesco de Meo, who has left the company.

Following the successful deconsolidation of Fresenius Medical Care, Helen Giza left the Management Board on November 30, 2023.

The #FutureFresenius strategy, with its realignment of the business segments into Operating and Investment Companies, is thus also reflected in the composition of the Fresenius Management Board. Therefore, the investment companies are no longer represented by a separate member of the Management Board.

The CVs of the members of the Supervisory Board and the Management Board can be found on our website at

Social Media

Follow us on Social Media

Share Price

Data is delayed by 15 minutes.

Share Price Information


Fresenius SE & Co. KGaA
Investor Relations
+49 (0) 6172 608-2485